We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Bionano Genomics Inc
173 own
98 watching
Current Price
$0.12
$-0.01
(-7.69%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
66.15M
52-Week High
1.36000
52-Week Low
0.12000000
Average Volume
16.95M
Dividend Yield
--
P/E Ratio
--
Market Capitalization66.15M52-Week High1.3600052-Week Low0.12000000Average Volume16.95MDividend Yield--P/E Ratio--What does the Bionano Genomics Inc do?
Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Read More
How much money does Bionano Genomics Inc make?
News & Events about Bionano Genomics Inc.
Globe Newswire
1 year ago
SAN DIEGO, June 21, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc.(BNGO), today announced that the company will participate at the Healthcare Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest. Erik Holmlin, Ph.D., Bionanos president and chief executive officer, is scheduled to ...
Globe Newswire
1 year ago
Grand prize winner, Dr. Michael Khodadoust at Stanford University in Palo Alto, California, will use the Saphyr system for research into CTCL (cutaneous t-cell lymphoma)Runner up prize winners are Dr. Afia Hasnain at The Hospital for Sick Children in Toronto, Canada, who will investigate ALL (acute ...
Globe Newswire
1 year ago
Preliminary Q1 total revenue expected to be between $7.3 and $7.5 million, which would represent an estimated increase of 28% to 32% over Q1 2022Installed base of Saphyr systems reached 259 as of March 31, 2023, which represents growth of the installed base by 19 systems in the quarter and an ...
Globe Newswire
1 year ago
Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome is among several forms of Mllerian agenesis, a disorder impacting 1 in 4,500 females which is indicated by the absence or underdevelopment of the female reproductive systemResearchers in the study hypothesized that a genome-wide structural variant (SV) ...
Globe Newswire
1 year ago
SAN DIEGO, March 15, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories today announced the expansion of its clinical testing menu with the launch of two new laboratory developed tests (LDTs) based on optical genome mapping (OGM), OGM-DxTM Postnatal Whole Genome SV and OGM-DxTM Prenatal Whole Genome SV. ...
Frequently Asked Questions
Frequently Asked Questions
What is Bionano Genomics Inc share price today?
Can Indians buy Bionano Genomics Inc shares?
How can I buy Bionano Genomics Inc shares from India?
Can Fractional shares of Bionano Genomics Inc be purchased?
What are the documents required to start investing in Bionano Genomics Inc stocks?
What is today’s traded volume of Bionano Genomics Inc?
What is today’s market capitalisation of Bionano Genomics Inc?
What is the 52-Week High and Low Range of Bionano Genomics Inc?
What percentage is Bionano Genomics Inc down from its 52-Week High?
What percentage is Bionano Genomics Inc up from its 52-Week Low?
Current Price
$0.12
$-0.01
(-7.69%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.